Cross-contamination, recently in the headlines as the source of “drug-doping” accusations at the 2021 Summer Olympics, is a rising concern in pharmaceutical manufacturing. As continuous manufacturing practices and quick production changeovers become the norm, even the slightest residual API left on processing surfaces can result in cross-contamination between drug types.
